Common Stock, Shares, Outstanding of MERRIMACK PHARMACEUTICALS INC from 31 Dec 2011 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
MERRIMACK PHARMACEUTICALS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2011 to 31 Mar 2024.
  • MERRIMACK PHARMACEUTICALS INC Common Stock, Shares, Outstanding for the quarter ending 31 Mar 2024 was 14,532,000, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

MERRIMACK PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 14,532,000 +277,000 +1.9% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 14,351,000 +136,000 +0.96% 31 Dec 2023 10-Q 15 May 2024 2024 Q1
Q3 2023 14,321,000 +911,000 +6.8% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 14,321,000 +911,000 +6.8% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 14,255,000 +845,000 +6.3% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 14,215,000 +805,000 +6% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 13,410,000 0 0% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 13,410,000 0 0% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 13,410,000 0 0% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 13,410,000 +30,000 +0.22% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 13,410,000 +30,000 +0.22% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 13,410,000 +30,000 +0.22% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 13,410,000 +30,000 +0.22% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 13,380,000 0 0% 31 Dec 2020 10-K 09 Mar 2022 2021 FY
Q3 2020 13,380,000 +17,000 +0.13% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 13,380,000 +31,000 +0.23% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 13,380,000 +37,000 +0.28% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 13,380,000 +37,000 +0.28% 31 Dec 2019 10-K 10 Mar 2021 2020 FY
Q3 2019 13,363,000 +20,000 +0.15% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 13,349,000 +6,000 +0.04% 30 Jun 2019 10-Q 17 Jul 2019 2019 Q2
Q1 2019 13,343,000 0 0% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 13,343,000 0 0% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 13,343,000 +69,000 +0.52% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 13,343,000 -119,398,000 -90% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 13,343,000 -118,568,000 -90% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 13,343,000 +323,000 +2.5% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 13,274,000 -116,161,000 -90% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 132,741,000 +3,750,000 +2.9% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 131,911,000 +15,500,000 +13% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 13,020,000 +1,433,000 +12% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 129,435,000 +14,334,000 +12% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 128,991,000 +18,193,000 +16% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 116,411,000 +7,025,000 +6.4% 31 Mar 2016 10-Q 02 May 2016 2016 Q1
Q4 2015 11,587,000 -95,110,000 -89% 31 Dec 2015 8-K 15 Dec 2017
Q3 2015 115,101,000 +9,446,000 +8.9% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 110,798,000 +6,285,000 +6% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 109,386,000 +6,025,000 +5.8% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 106,697,000 +4,174,000 +4.1% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 105,655,000 +3,380,000 +3.3% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 104,513,000 +8,153,000 +8.5% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 103,361,000 +7,413,000 +7.7% 31 Mar 2014 10-Q 06 May 2014 2014 Q1
Q4 2013 102,523,000 +6,698,000 +7% 31 Dec 2013 10-K 27 Feb 2015 2014 FY
Q3 2013 102,275,000 +8,246,000 +8.8% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 96,360,000 +2,820,000 +3% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 95,948,000 +84,041,000 +706% 31 Mar 2013 10-Q 13 May 2013 2013 Q1
Q4 2012 95,825,000 +83,991,000 +710% 31 Dec 2012 10-K 04 Mar 2014 2013 FY
Q3 2012 94,029,000 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 93,540,000 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 11,907,000 31 Mar 2012 10-Q 15 May 2012 2012 Q1
Q4 2011 11,834,000 31 Dec 2011 10-K 20 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.